TG Therapeutics Inc/ US88322Q1085 /
| 2024-04-22 10:00:00 PM | Chg. +0.3200 | Volume | Bid1:35:09 PM | Ask1:35:09 PM | High | Low |
|---|---|---|---|---|---|---|
| 14.1000USD | +2.32% | 2.27 mill. Turnover: 26.4 mill. |
14.0400Bid Size: 100 | 14.5700Ask Size: 100 | 14.3100 | 13.6550 |
GlobeNewswire
04-18
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
04-18
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...
GlobeNewswire
04-15
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...
GlobeNewswire
03-08
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Scle...
GlobeNewswire
03-01
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Co...
GlobeNewswire
02-28
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Resu...
GlobeNewswire
02-27
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
GlobeNewswire
02-23
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Bu...
GlobeNewswire
02-20
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Scle...
GlobeNewswire
01-09
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development an...
GlobeNewswire
01-05
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-11-27
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
GlobeNewswire
2023-11-03
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (IN...
GlobeNewswire
2023-11-01
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-10-30
TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update
GlobeNewswire
2023-10-12
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatm...
GlobeNewswire
2023-10-11
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatm...
GlobeNewswire
2023-10-02
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee ...
GlobeNewswire
2023-09-22
TG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
GlobeNewswire
2023-09-07
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2022-03-10
TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting
GlobeNewswire
2022-03-04
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab ...
